Wednesday, September 17 - ET (Eastern Time, GMT-05:00)
CPE Credits Available: 0.3
- Market outlook
- Deals and trends
- What to expect in regard to tariffs
- New administration impacts on life sciences
CPE Credits Available: 1.2
- Business development opportunities & fundraising strategies
- Collaborations, mergers, partnering
- Career path
- Career advancement
- Non-traditional and traditional upleveling techniques
- Top of mind for leadership in 2025 and beyond
CPE Credits Available: 1.2
- Sophia Shah - Partner, Tax, Crowe LLP
- Colleen Tupper - Chief Financial Officer, Collegium
- Adam Mostafa - Chief Financial Officer, X4 Pharmaceuticals
- Jon Freve - Chief Financial Officer, Alentis Therapeutics
- Rakhi Kumar - Board Member, Neuropace
- Daniel Rosan - Chief Financial Officer, Ascidian Therapeutics
- Cost estimation
- Resource allocation
- Risk management
- Compliance
- Reimbursement
- Trial design impact
CPE Credits Available: 1.2
- Jennifer Kyle - Founder and CEO, Condor Software
- Laverne August - Global Strategic Outsourcing & Procurement, Executive Director, Syndax Pharmaceuticals
- Juan Betanzo - Vice President, Strategic Finance, EyePoint
- Valuations
- Different market requirements whether public or private
- Methods for valuation modeling
- Scenario planning
- Cash runway management
CPE Credits Available: 1.2
- Catherine Chan - Senior Director, Financial Planning & Analysis, Chroma Medicine
- Patrick Coyle - Founder, Novus Proximus
- Julio Martinez - CEO, Co-Founder, Abacum
- Revenue Recognition
- ACS 606 Compliance
- Licensing arrangements
- R&D Accounting
- Expense capitalization vs. Expensing
- Collaboration agreements
- GHG Emissions
- Overview of Scope 1, 2, and 3
- Calculations & how they are factored
CPE Credits Available: 1.2
- David Pieters - Vice President , Finance, Biotheryx
- Sarah Stiff - ESG Controller, Legend Biotech
- Writing emails and policies
- Accounting operations automation
- Daily activities where users see benefit
CPE Credits Available: 1.2
- Organizations building reputation during times of uncertainty
- Retaining talent
- New skills to consider with attention to AI focus
CPE Credits Available: 1.2
Unlock Your Launch Potential: GTN Training for Emerging Biopharma
Ready to transform your first commercial launch into a success story? Our GTN Training equips emerging biopharma teams with the essential building blocks for launch excellence — from crafting the right organizational structure to aligning finance and commercial goals, and developing a winning product, pricing, distribution, and reimbursement strategy.
Learn how to anticipate compliance requirements, master the GTN process, and confidently forecast with real-world analogs and analytics with this 4 part series.
Gain the knowledge, tools, and insights you need to build a scalable foundation — and set your product up for lasting success.
Course 3: Crafting Smart Pricing & Contracting Strategies
- How to align Phase III data with contracting and payer needs
- How to develop pricing models that balance access and profitability
- How to forecast and accrue accurately using real-world analogs
CPE Credits Available: 2.0